Related Experiment Video
Updated: Apr 16, 2026

Intravitreal Injections in the Ovine Eye
Published on: July 5, 2022
Leber Hereditary Optic Neuropathy - Therapeutic Challenges and Early Promise
Patrick Yu-Wai-Man1, Patrick F Chinnery2
1Mitochondrial Research Group, Institute of Genetic Medicine, Centre for Life, Newcastle University, NE1 3BZ, UK ; Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
Abstract:
Leber hereditary optic neuropathy (LHON) is the most common primary mitochondrial DNA (mtDNA) disorder in the general population. It is an important cause of severe, usually irreversible, visual loss among young adults with a peak age of onset in the second and third decades of life. Management is currently mostly supportive but recent developments in LHON research are pointing the way towards more effective treatments for this blinding mitochondrial disorder.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview

